Luffa Tablet, Orally Disintegrating
FDA Label NDC 60986-2025

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Marco Pharma International Llc. for the product Luffa (NDC 60986-2025). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, dosage, warnings, dosage & administration, inactive ingredients, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Purging Luffa 6xHPUS

Goldenseal 4xHPUS

Cinnabaris 4xHPUS

Onion 6xHPUS

Salt 6xHPUS

Phosphorus 6xHPUS

Boneset 5xHPUS

Lungwort 2xHPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

For relief of sinus symptoms; hay-fever.

Dosage

Adults take 1 tablet three times daily, dissolving on the tongue. For severe symptoms, take 1 tablet every hour until improvement is felt. Children receive 1/2 or less the adult amount.

Warnings

If pregnant or breast-feeding, consult a health professional before use.

Dosage & Administration

(Read Suggested Use Section)

Inactive Ingredients

In a Lactose base

Package Label.Principal Display Panel

Luffa.jpg

* Please review the disclaimer below.